Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis

NCT00532337 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

285

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis
Osteopenia

Interventions

DRUG: ONO-5334
DRUG: ONO-5334
DRUG: ONO-5334
DRUG: ONO-5334
DRUG: ONO-5334

Sponsor

Ono Pharma USA Inc